RDEA119 and Sorafenib Combination Dose Escalation Study
This study has been completed.
Sponsor:
Ardea Biosciences, Inc.
Information provided by (Responsible Party):
Ardea Biosciences, Inc.
ClinicalTrials.gov Identifier:
NCT00785226
First received: November 4, 2008
Last updated: March 11, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | September 2012 |
| Primary Completion Date: | April 2012 (Final data collection date for primary outcome measure) |